Banner

GWAS-related eQTLs across different cancer types

We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions ( ≥ 0.5).



e.g., "STAD"
e.g., "r²>= 0.8"
e.g., "rs2273"
Cancer type
eQTL type
tagSNP
LD
SNP ID
SNP position (hg19)
Gene symbol
Gene position (hg19)
Beta
t-stat
p-value
GWAS-Traits
BLCA cis rs2985684 1 rs1957977 chr14:50090603 RPL36AL chr14:50085407-50087349:- 0.24 4.44 1.16E-5 Carotid intima media thickness
BLCA cis rs1577917 1 rs1962716 chr6:86648436 SNHG5 chr6:86386726-86388451:- -0.54 -9.5 2.33E-19 Response to antipsychotic treatment
BLCA cis rs2243480 1 rs1964692 chr7:65454183 CCT6P1 chr7:65216092-65228661:+ 0.31 4.38 1.54E-5 Diabetic kidney disease
BLCA cis rs1971762 1 rs1971762 chr12:54058238 ATP5G2 chr12:54058945-54070512:- 0.22 4.86 1.71E-6 Height
BLCA cis rs6547741 1 rs1972669 chr2:27767107 C2orf16 chr2:27799389-27805588:+ 0.23 3.97 8.5E-5 Oral cavity cancer
BLCA cis rs41266839 1 rs1979 chr6:26377591 BTN3A2 chr6:26365398-26378546:+ -0.74 -12.03 1.76E-28 Schizophrenia
BLCA cis rs2243480 1 rs1979823 chr7:65704613 CCT6P1 chr7:65216092-65228661:+ -0.33 -4.52 8.25E-6 Diabetic kidney disease
BLCA cis rs6918586 1 rs198806 chr6:26133616 BTN3A2 chr6:26365398-26378546:+ 0.2 4.12 4.66E-5 Schizophrenia
BLCA cis rs6918586 1 rs198811 chr6:26128446 BTN3A2 chr6:26365398-26378546:+ -0.19 -4.03 6.7E-5 Schizophrenia
BLCA cis rs199347 1 rs199347 chr7:23293746 GPNMB chr7:23286316-23314728:+ -0.25 -4.26 2.6E-5 Parkinson's disease
BLCA cis rs199347 1 rs199348 chr7:23293098 GPNMB chr7:23286316-23314728:+ -0.23 -3.83 0.000148 Parkinson's disease
BLCA cis rs199347 1 rs199351 chr7:23300049 GPNMB chr7:23286316-23314728:+ -0.25 -4.1 4.99E-5 Parkinson's disease
BLCA cis rs199347 1 rs199357 chr7:23288309 GPNMB chr7:23286316-23314728:+ 0.24 4.02 6.96E-5 Parkinson's disease
BLCA cis rs9815354 1 rs1994157 chr3:41897482 ULK4 chr3:41288091-42003660:- 0.64 9.5 2.29E-19 Diastolic blood pressure
BLCA cis rs1577917 1 rs1995688 chr6:86632319 SNHG5 chr6:86386726-86388451:- -0.51 -9.03 8.38E-18 Response to antipsychotic treatment